Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.08M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$653K$1.3M2025 · bought $0 · sold $1.3M20252026 · bought $0 · sold $656K2026
Total +$0.0000 bought · $1.96M sold

All filings on record

Every Form 4 transaction we track for this filer

ARQTSell
2026-06-17 · Arcutis Biotherapeutics, Inc.
$16.3K
ARQTSell
2026-06-15 · Arcutis Biotherapeutics, Inc.
$100.0K
ARQTExercise
2026-06-15 · Arcutis Biotherapeutics, Inc.
$19.5K
ARQTExercise
2026-06-15 · Arcutis Biotherapeutics, Inc.
$7.7K
ARQTExercise
2026-06-15 · Arcutis Biotherapeutics, Inc.
$5.4K
ARQTGrant
2026-06-05 · Arcutis Biotherapeutics, Inc.
5,778
ARQTSell
2026-02-02 · Arcutis Biotherapeutics, Inc.
$250.5K
ARQTSell
2026-01-02 · Arcutis Biotherapeutics, Inc.
$289.6K
ARQTSell
2025-12-01 · Arcutis Biotherapeutics, Inc.
$302.1K
ARQTSell
2025-11-03 · Arcutis Biotherapeutics, Inc.
$252.7K
ARQTSell
2025-10-01 · Arcutis Biotherapeutics, Inc.
$8.7K
ARQTSell
2025-10-01 · Arcutis Biotherapeutics, Inc.
$180.5K
ARQTExercise
2025-10-01 · Arcutis Biotherapeutics, Inc.
$16.0K
ARQTSell
2025-09-02 · Arcutis Biotherapeutics, Inc.
$156.4K
ARQTExercise
2025-09-02 · Arcutis Biotherapeutics, Inc.
10,000
ARQTSell
2025-08-01 · Arcutis Biotherapeutics, Inc.
$55.6K
ARQTExercise
2025-08-01 · Arcutis Biotherapeutics, Inc.
3,890
ARQTSell
2025-08-01 · Arcutis Biotherapeutics, Inc.
$87.4K
ARQTExercise
2025-08-01 · Arcutis Biotherapeutics, Inc.
6,110
ARQTSell
2025-07-01 · Arcutis Biotherapeutics, Inc.
$127.4K
ARQTSell
2025-06-18 · Arcutis Biotherapeutics, Inc.
$135.6K
ARQTGrant
2025-06-12 · Arcutis Biotherapeutics, Inc.
7,609

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.